期刊文献+

女性Duchenne/Becker型肌营养不良症携带者发病机理的研究进展 被引量:3

Advances in the Pathogenic Research of Female Carriers with Symptomatic Duchenne Muscular Dystrophy
原文传递
导出
摘要 Duchenne/Becker型肌营养不良(DMD/BMD)是一类常见的X连锁隐性遗传病,多见于男性患者,女性携带者一般不发病,因为女性体内会发生随机的X染色体失活,而使体内呈现镶嵌型。目前,越来越多的文献报道DMD/BMD女性携带者发病的病例,其症状有轻有重,但发病机制尚不明了,大多数研究认为与X染色体的偏斜失活有关,即携带DMD突变的X染色体异常活化,使正常DMD基因弱或无表达,从而无法生成正常功能的dystrophin蛋白,表现为DMD/BMD。本文主要综述了X偏斜失活与DMD女性携带者发病相关性的研究进展。 DMD/BMD is a X-linked recessive hereditary disease.It predominantly affects males.While female carriers do not have symptoms,due to their inactive X chromosome make it present mosaic.Recently,more and more papers reported that a clinically significant proportion of DMD/BMD female carriers have symptoms.They presented variable degrees of symptoms.But the mechanism of the pathogencity is still not clear.Most of the research considered that the dominating reason is the skewed X inactivation.It means that the predominant expression of the DMD mutant allele make the normal one have weak expression,thus no function dystrophin proteins could be generate,manifested as DMD/BMD.In this paper,we mainly summarized the relationship between skewed X inactivation and pathogenicity of the symptomatic DMD female carriers.
出处 《现代生物医学进展》 CAS 2017年第25期4986-4989,共4页 Progress in Modern Biomedicine
基金 国家重点基础研究发展计划(2015cb9449020)
关键词 Duchenne/Becker型肌营养不良 女性携带者 X偏斜失活 DMD/BMD Female carriers Skewed X inactivation
  • 相关文献

参考文献1

二级参考文献30

  • 1Zubrzycka- Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut H J, Talbot J, Hodges RS, Ray PN, WortonRG. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature, 1988, 333:466-469.
  • 2Davies KE, Smith TJ, Bundey S, Read AP, Flint T, Bell M, Speer A. Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome. J Med Genet, 1988, 25:9-13.
  • 3Brabec P, Vondr6cek P, Klimes D, Baumeister S, Lochmuller H, Pavlik T, Gregor J. Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry approach. Neuromuscul Disord, 2009, 19:250-254.
  • 4Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol, 2003, 2:731-740.
  • 5Cunniff C, Andrews J, Meaney FJ, Mathews KD, Matthews D, Ciafaloni E, Miller TM, Bodensteiner JB, Miller LA, James KA, Druschel CM, Romitti PA, Pandya S. Mutation analysis in a population- based cohort of boys with Duchenne or Becker muscular dystrophy. J Child Neurol, 2009, 24:425-430.
  • 6Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol, 2010, 9:77-93.
  • 7Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, Sugita H, Kunkel LM. Exploring the molecular basis fur variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet, 1991, 49:54-67.
  • 8Ramelli GP, Joncourt F, Luetschg J, Weis J, Tolnay M, Burgunder JM. Becker muscular dystrophy with marked divergence between clinical and molecular genetic findings: case series. Swiss Med Wkly, 2006, 136(11/12):189-193.
  • 9Benedetti S, Hoshiya H, Tedesco FS. Repair or replace: exploiting novel gene and cell therapy strategies for muscular dystrophies? FEBS J, 2013, 280:4263-4280.
  • 10Foster H, Popplewell L, Dickson G. Genetic therapeutic approaches for Duchenne muscular dystrophy. Hum Gene Ther, 2012, 23:676-687.

共引文献29

同被引文献30

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部